Meet Our Experts

Kelley Dawson

Senior Clinical Data Manager
Positions & Honors
Contributions to Science
Additional Information
Originally From:
Fun Fact:

Ms. Dawson is a Senior Clinical Data Manager at Proxima Clinical Research, a partner for the emerging biotech and medical device industry. Over her nearly 30-year career, she has served primarily in a data management role with expertise in the global data management of Phase I-IV paper and EDC studies in multiple therapeutic areas.  

As an adult learner, Ms. Dawson received a B.S. in Management and Organizational Development, from the University of Mount Olive in 2003.  


University of Mount Olive: Management and Organizational Development, B.S.

Positions & Honors

Proxima Clinical Research, Inc., Houston, Texas
Sr. Clinical Data Manager

Lexitas Pharma Services, Inc., Durham, NC  
Sr. Clinical Data Lead

IQVIA, Durham, NC
Data Team Lead

Syneos Health, Raleigh, NC  
Senior Clinical Data Manager

Triangle Biostatistics, Wake Forest, NC  
Senior Clinical Data Manager

Quintiles, Durham, NC
Associate Data Team Lead

Chiltern International, Wilmington, NC  
Data Management Project Leader

PPC Inc., Wilmington NC
Senior Clinical Data Analyst

Clinical Data Analyst

Global Planning and Logistics

Quality Reviewer

Associate Quality Reviewer

Clinical Data Associate

Senior Data Entry Operator

Data Entry Operator

Data Recovery Specialist

Contributions to Science

Ms. Dawson’s career spans across a wide array of therapeutic area experience including, but not limited to the following areas/trial work:  

  • Audiology - Otitis Media, Phase III
  • Cardiovascular - CHF, Phase III
  • Cardiovascular - Hypertension, Phase II-III
  • Dermatology - Plaque Psoriasis, Phase II-III
  • Endocrinology - Diabetes, Phase I-IV
  • Epidemiology - Tuberculosis, Phase III
  • Gastroenterology - Peptic Ulcer, Phase II-III
  • Gastroenterology - Ulcerative Colitis, Phase II-III
  • Hematology/Oncology - Chemotherapy Induced Anemia, Phase IV
  • Hematology/Oncology - Anemia in Low to Intermediate –1 Risk Myelodysplastic Syndrome, Phase III
  • Hepatology - Hepatitis C, Phase II
  • Hepatology - Naïve Subjects with Chronic Genotype I HCV, Phase III
  • Immunology - Genital Herpes, Phase III
  • Immunology - HIV, Phase II-IV
  • Men’s Health - Erectile Dysfunction, Phase II-III
  • Oncology - Breast Cancer, Phase III  
  • Oncology - CLL / MCL, Phase III
  • Oncology - Lung Cancer, Phase II-IV
  • Oncology - Prostate Cancer, Phase II
  • Ophthalmology - Acquired Blepharoptosis, Phase I/IIa  
  • Ophthalmology - Advanced Non-Neovascular Age-Related Macular Degeneration, Phase I/IIa
  • Ophthalmology - Dry Eye Associate with Sjögren’s Syndrome, Phase III
  • Ophthalmology - Geographic Atrophy (GA) or Choroidal Neovascularization (CNV) with Intermediate to Advanced Dry Age-Related Macular Degeneration, Phase II  
  • Ophthalmology - Intravitreal Microplasmin with Vitrectomy Surgery, Phase IIb  
  • Ophthalmology - Macula-off Rhegmatogenous Retinal Detachment, Phase II  
  • Ophthalmology - PRPF31 Mutation – Associated Retinal Dystrophy, Observational
  • Ophthalmology - Primary Open Angle Glaucoma, Phase II
  • Adolescent Insomnia, Phase I
  • Psychology - Adolescent Insomnia, Phase I
  • Respiratory - Asthma, Phase I  
  • Respiratory - Pediatric RSV, Phase II
  • Rheumatology - Gout, Phase I-II  
  • Rheumatology - Rheumatoid Arthritis, Phase II  
  • Rheumatology - Rheumatoid Arthritis, Phase IIIb
  • Women’s Health - Post Menopause Hormone Replacement Therapy, Phase II
Additional Information

In addition, Ms. Dawson has SAS programming experience validating Tables, Listings and Figures in the Biostatistics space.  

Recent Articles:
Read More Posts